Optimizing Mineralocorticoid Receptor Antagonist Therapy in Heart Failure Through Integrated Care Strategies

已完结 20 由不可一世发布于 2026/8/13 19:51:53

DOI:10.1016/j.jacadv.2026.102845
作者：Tina B. Marvasti MD, PhD,?Kevin R. Murray MD,?Gloria Ho MSc,?Holden Lowes MSc,?Stella Kozuszko NP,?Margaret Brum MS, RD,?Natasha Verhoeff MD,?Chun Po S. Fan PhD,?Jacob A. Udell MD, MPH,?Steven Gregory
文献类型：期刊论文
补充材料：只需要正文

其它数据库

Abstract：BackgroundHyperkalemia is a critical barrier to mineralocorticoid receptor antagonist (MRA) optimization in heart failure (HF) patients with reduced ejection fraction (HFrEF).ObjectivesThe o

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:NatureDecarbonizing global steel production